Lowering PSA cutoffs to enhance detection of curable prostate cancer
- 1 June 2000
- Vol. 55 (6) , 791-795
- https://doi.org/10.1016/s0090-4295(99)00602-0
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI Journal of the National Cancer Institute, 1999
- Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseUrology, 1999
- The early detection of prostate carcinoma with prostate specific antigenCancer, 1997
- Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancerPublished by American Medical Association (AMA) ,1997
- Longitudinal screening for prostate cancer with prostate-specific antigenPublished by American Medical Association (AMA) ,1996
- Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the EvidenceNew England Journal of Medicine, 1995
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screeningPublished by American Medical Association (AMA) ,1993
- Prevalence and Pathological Extent of Prostate Cancer in Men with Prostate Specific Antigen Levels of 2.9 to 4.0 NG./ML.Journal of Urology, 1993
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991